Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,796	2,702	1,481	1,407	3,029	1,147
Market Cap Growth	79.38%	82.43%	5.29%	-53.56%	164.18%	94.21%
Enterprise Value	1,489	2,352	1,146	1,039	2,606	888
PE Ratio	-	-11.00	-6.68	-8.32	-21.68	-14.84
PB Ratio	4.07	5.49	3.03	3.09	6.02	3.73
P/FCF Ratio	-11.63	-12.78	-7.93	-10.92	-29.21	-13.04
P/OCF Ratio	-12.55	-13.86	-8.31	-11.61	-40.58	-17.73
EV/EBITDA Ratio	-8.89	-9.94	-5.36	-6.46	-20.60	-12.53
EV/EBIT Ratio	-8.62	-9.65	-5.21	-6.25	-19.63	-12.45
EV/FCF Ratio	-10.17	-11.13	-6.13	-8.06	-25.13	-10.10
Debt / Equity Ratio	0.06	0.05	0.05	0.05	0.12	0.15
Debt / EBITDA Ratio	-0.11	-0.11	-0.11	-0.14	-0.49	-0.67
Debt / FCF Ratio	-0.12	-0.12	-0.12	-0.18	-0.59	-0.54
Quick Ratio	10.08	7.73	9.15	17.62	14.86	16.72
Current Ratio	10.47	7.80	9.30	17.69	14.94	16.81
Interest Coverage	-131.76	-129.98	-118.15	-55.79	-19.05	-11.97
Return on Equity (ROE)	-53.10%	-51.80%	-53.40%	-35.40%	-43.10%	-32.00%
Return on Assets (ROA)	-46.90%	-45.90%	-47.70%	-31.60%	-33.80%	-25.30%
Return on Capital (ROIC)	-56.66%	-50.16%	-43.77%	-35.04%	-23.76%	-21.47%
Earnings Yield	-13.88%	-9.09%	-14.98%	-12.02%	-4.61%	-6.74%
FCF Yield	-11.68%	-7.82%	-12.61%	-9.16%	-3.42%	-7.67%
Buyback Yield / Dilution	-17.74%	-23.27%	-7.77%	-14.18%	-13.00%	-24.46%
Total Shareholder Return	-17.74%	-23.27%	-7.77%	-14.18%	-13.00%	-24.46%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).